Gene Location [1]
Cell cycle control
Variant Type

CDK6 Amplification is present in 0.57% of AACR GENIE cases, with esophageal adenocarcinoma, lung adenocarcinoma, pancreatic adenocarcinoma, breast invasive ductal carcinoma, and conventional glioblastoma multiforme having the greatest prevalence [4].

Top Disease Cases with CDK6 Amplification

Significance of CDK6 Amplification in Diseases

Medulloblastoma +

Malignant Solid Tumor +

Malignant Glioma +

Medulloblastoma, Non-WNT/Non-SHH +

Large Cell/Anaplastic Medulloblastoma +

Central Nervous System Embryonal Neoplasm +

Glioblastoma +

Breast Carcinoma +

Soft Tissue Sarcoma +

Ovarian Carcinoma +

Central Nervous System Ganglioneuroblastoma +

Central Nervous System Neuroblastoma +

Desmoplastic/Nodular Medulloblastoma +

Medulloblastoma With Extensive Nodularity +

Medulloblastoma, SHH-Activated +

Medulloblastoma, WNT-Activated +

Medulloepithelioma +

Adenocarcinoma Of The Gastroesophageal Junction +

Gallbladder Carcinoma +

Anaplastic Ependymoma +

Gastric Adenocarcinoma +

Anaplastic Astrocytoma +

Bile Duct Carcinoma +

Pancreatic Carcinoma +

High-Grade Glioma, NOS +

Diffuse Glioma +

Head And Neck Squamous Cell Carcinoma +

Esophageal Squamous Cell Carcinoma +

Osteosarcoma +

Head And Neck Carcinoma +

Melanoma +

Cancer +

Non-Small Cell Lung Carcinoma +

Lung Carcinoma +

Cervical Carcinoma +

Colorectal Carcinoma +

Squamous Cell Lung Carcinoma +

Bladder Carcinoma +

Malignant Uterine Neoplasm +

Ovarian Epithelial Tumor +

Anaplastic Astrocytoma, IDH-Mutant +

Anaplastic Oligodendroglioma +

Anaplastic Oligodendroglioma, IDH-Mutant And 1p/19q-Codeleted +

Anaplastic Pleomorphic Xanthoastrocytoma +

Atypical Teratoid/Rhabdoid Tumor +

Bronchogenic Carcinoma +

Chondrosarcoma +

Chordoma +

Dedifferentiated Chondrosarcoma +

Diffuse Midline Glioma, H3 K27M-Mutant +

Embryonal Tumor With Multilayered Rosettes, C19MC-Altered +

Embryonal Tumor With Multilayered Rosettes, Not Otherwise Specified +

Endometrial Endometrioid Adenocarcinoma +

Ependymoma +

Ependymoma, RELA Fusion-Positive +

Fallopian Tube Carcinoma +

Meningioma +

Pineoblastoma +

Primary Peritoneal Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.